PMP22 antisense oligonucleotides reverse Charcot-Marie-Tooth disease type 1A features in rodent models.
about
Antisense oligonucleotides offer hope to patients with Charcot-Marie-Tooth disease type 1A.Antisense oligonucleotides in neurological disorders.Regulation of the neuropathy-associated Pmp22 gene by a distal super-enhancerTargeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy
P2860
PMP22 antisense oligonucleotides reverse Charcot-Marie-Tooth disease type 1A features in rodent models.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
PMP22 antisense oligonucleotid ...... 1A features in rodent models.
@en
PMP22 antisense oligonucleotid ...... 1A features in rodent models.
@nl
type
label
PMP22 antisense oligonucleotid ...... 1A features in rodent models.
@en
PMP22 antisense oligonucleotid ...... 1A features in rodent models.
@nl
prefLabel
PMP22 antisense oligonucleotid ...... 1A features in rodent models.
@en
PMP22 antisense oligonucleotid ...... 1A features in rodent models.
@nl
P2093
P2860
P356
P1476
PMP22 antisense oligonucleotid ...... 1A features in rodent models.
@en
P2093
Aneeza Kim
Apoorva Mohan
Eric E Swayze
Hien Tran Zhao
Holly B Kordasiewicz
Karli Ikeda-Lee
Mark A Scheideler
Sagar Damle
P2860
P304
P356
10.1172/JCI96499
P407
P50
P577
2017-12-04T00:00:00Z